Skip to main content

Peer Review reports

From: A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): a structured summary of a study protocol for a randomized controlled trial

Original Submission
16 Jul 2020 Submitted Original manuscript
20 Jul 2020 Reviewed Reviewer Report - Kirsty Loudon
Resubmission - Version 2
Submitted Manuscript version 2
26 Jul 2020 Editorially accepted
5 Aug 2020 Article published 10.1186/s13063-020-04632-4

You can find further information about peer review here.

Back to article page